1. Home
  2. THRD vs AVD Comparison

THRD vs AVD Comparison

Compare THRD & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • AVD
  • Stock Information
  • Founded
  • THRD 2019
  • AVD 1969
  • Country
  • THRD United States
  • AVD United States
  • Employees
  • THRD N/A
  • AVD N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • AVD Agricultural Chemicals
  • Sector
  • THRD Health Care
  • AVD Industrials
  • Exchange
  • THRD Nasdaq
  • AVD Nasdaq
  • Market Cap
  • THRD 164.2M
  • AVD 135.6M
  • IPO Year
  • THRD 2022
  • AVD N/A
  • Fundamental
  • Price
  • THRD $5.14
  • AVD $4.09
  • Analyst Decision
  • THRD Hold
  • AVD Strong Buy
  • Analyst Count
  • THRD 3
  • AVD 1
  • Target Price
  • THRD $5.00
  • AVD $14.00
  • AVG Volume (30 Days)
  • THRD 1.2M
  • AVD 192.9K
  • Earning Date
  • THRD 05-14-2025
  • AVD 05-08-2025
  • Dividend Yield
  • THRD N/A
  • AVD 0.73%
  • EPS Growth
  • THRD N/A
  • AVD N/A
  • EPS
  • THRD N/A
  • AVD N/A
  • Revenue
  • THRD N/A
  • AVD $553,839,000.00
  • Revenue This Year
  • THRD N/A
  • AVD N/A
  • Revenue Next Year
  • THRD N/A
  • AVD $4.35
  • P/E Ratio
  • THRD N/A
  • AVD N/A
  • Revenue Growth
  • THRD N/A
  • AVD N/A
  • 52 Week Low
  • THRD $3.18
  • AVD $3.28
  • 52 Week High
  • THRD $16.94
  • AVD $12.67
  • Technical
  • Relative Strength Index (RSI)
  • THRD 79.10
  • AVD 48.02
  • Support Level
  • THRD $5.08
  • AVD $3.28
  • Resistance Level
  • THRD $5.20
  • AVD $4.50
  • Average True Range (ATR)
  • THRD 0.11
  • AVD 0.25
  • MACD
  • THRD 0.13
  • AVD 0.08
  • Stochastic Oscillator
  • THRD 96.84
  • AVD 66.39

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: